BSE Live
Dec 26, 16:01Prev. Close
1737.50
Open Price
1727.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:54Prev. Close
1737.00
Open Price
1737.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1719.50 (508)
| Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 13,752.13 | 11,087.89 | 9,408.43 | 4,481.32 | 2,799.37 | |
| Net CashFlow From Operating Activities | 14,072.09 | 12,134.98 | 4,959.33 | 8,984.54 | 6,170.37 | |
| Net Cash Used In Investing Activities | -5,306.16 | -690.20 | -7,943.68 | -5,724.74 | 536.22 | |
| Net Cash Used From Financing Activities | -7,905.82 | -6,710.16 | 2,376.07 | -5,193.46 | -5,980.48 | |
| Foreign Exchange Gains / Losses | 123.04 | -73.99 | 157.07 | 127.43 | -129.69 | |
| Adjustments On Amalgamation Merger Demerger Others | -0.03 | 1.29 | 566.69 | 41.45 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 983.12 | 4,661.92 | 115.48 | -1,764.78 | 596.42 | |
| Cash And Cash Equivalents Begin of Year | 9,285.65 | 4,623.73 | 4,508.25 | 6,273.03 | 5,676.61 | |
| Cash And Cash Equivalents End Of Year | 10,268.77 | 9,285.65 | 4,623.73 | 4,508.25 | 6,273.03 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend